Linden Thomas Advisory Services, LLC

Position in MRK — Merck & Co., Inc.

CIK 1965702 Charlotte, NC

Position in MRK

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$3,226,121

+$276,130 QoQ

Shares Held

25,106

+2.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#1,295

of 3,769 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $22,830,139 across 6 Drug Manufacturers - General names. MRK ranks #4 (14.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,333	$7,595,990
2	ABBV	AbbVie Inc.	15,041	$3,784,917
3	GILD	Gilead Sciences, Inc.	27,150	$3,430,131
4	MRK	Merck & Co., Inc. This page	25,106	$3,226,121
5	AMGN	Amgen Inc	8,364	$3,028,771
6	BMY	Bristol Myers Squibb Co	30,618	$1,764,209

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,226,121	25,106	+2.4%	Shares	Sole	2026-07-16
2026-03-31	$2,949,991	24,524	+98.0%	Shares	Sole	2026-04-10
2025-12-31	$1,303,434	12,383	+1.8%	Shares	Sole	2026-01-16
2025-09-30	$1,020,672	12,161	+1.5%	Shares	Sole	2025-11-06
2025-06-30	$948,020	11,976	+2.7%	Shares	Sole	2025-07-31
2025-03-31	$1,046,511	11,659	+6.6%	Shares	Sole	2025-04-30
2024-12-31	$1,087,614	10,933	+6.8%	Shares	Sole	2025-01-21
2024-09-30	$1,162,513	10,237	+4.5%	Shares	Sole	2024-10-17
2024-06-30	$1,213,116	9,799	+8.1%	Shares	Sole	2024-07-10
2024-03-31	$1,195,730	9,062	+7.2%	Shares	Sole	2024-04-30
2023-12-31	$921,982	8,457	-3.0%	Shares	Sole	2024-02-01
2023-09-30	$897,621	8,719	—	Shares	Sole	2023-10-20
No filing history on record for this holder in this stock.